Chronic lymphocytic leukemia after chronic myeloid leukemia in the same patient: two different genomic events and a common treatment?
D'Arena, Giovanni; Gemei, Marica; Luciano, Luigiana; D'Auria, Fiorella; Deaglio, Silvia; Statuto, Teodora; Bianchino, Gabriella; Grieco, Vitina; Mansueto, Giovanna; Guariglia, Roberto; Pietrantuono, Giuseppe; Martorelli, Maria Carmen; Villani, Oreste; Del Vecchio, Luigi; Musto, Pellegrino.
J Clin Oncol
; 30(32): e327-30, 2012 Nov 10.
Artigo em Inglês | MEDLINE | ID: mdl-23008321
A case report of systemic mastocytosis associated with multiple hematologic non-mast cell lineage diseases.
Characteristics, combinations, treatments, and survival of second primary hematological neoplasm: a retrospective single-center cohort of 49 patients (Hemo<sup>2</sup>study).
Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment.
[Sublobar Resection for Patients with a Metachronous Second Primary Lung Cancer Following Curative Resection of a Primary Lung Cancer].
Comprehensive Genomic Profiling Aids in Distinguishing Metastatic Recurrence from Second Primary Cancers.
Simultaneous and sequential concurrent myeloproliferative and lymphoproliferative neoplasms.
Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia.
Therapy-related myeloid neoplasms.
Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study.
Current and Emerging Therapies in Metastatic Pancreatic Cancer.